Screening for


Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
Feb 2021
Historique:
entrez: 26 2 2021
pubmed: 27 2 2021
medline: 1 6 2021
Statut: ppublish

Résumé

Background

Identifiants

pubmed: 33632376
doi: 10.2807/1560-7917.ES.2021.26.8.1900730
pmc: PMC7908068
doi:

Substances chimiques

Antifungal Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

N Engl J Med. 2018 Oct 4;379(14):1322-1331
pubmed: 30281988
Med Mycol. 2018 Oct 16;:
pubmed: 30329075
PLoS Pathog. 2017 May 18;13(5):e1006290
pubmed: 28542486
Microbiol Immunol. 2009 Jan;53(1):41-4
pubmed: 19161556
JAMA. 2009 Dec 2;302(21):2323-9
pubmed: 19952319
Int J Mol Sci. 2011;12(10):7038-47
pubmed: 22072934
Antimicrob Agents Chemother. 2018 Nov 26;62(12):
pubmed: 30249685
Clin Microbiol Rev. 2017 Nov 15;31(1):
pubmed: 29142078
Clin Infect Dis. 2017 Jan 15;64(2):134-140
pubmed: 27988485
Med Mycol. 2016 Jan;54(1):80-8
pubmed: 26591008
J Infect. 2018 Nov;77(5):448-454
pubmed: 30063914
Med Mycol. 2017 Jul 1;55(5):563-567
pubmed: 28204557
Antimicrob Resist Infect Control. 2016 Oct 19;5:35
pubmed: 27777756
J Clin Microbiol. 2018 Jan 24;56(2):
pubmed: 29187562
Clin Infect Dis. 2002 Dec 15;35(12):1477-83
pubmed: 12471566
Clin Infect Dis. 2018 Jan 6;66(2):306-311
pubmed: 29020224
J Fungi (Basel). 2019 Sep 30;5(4):
pubmed: 31574934
Euro Surveill. 2018 Nov;23(46):
pubmed: 30458912
J Clin Microbiol. 2017 Oct;55(10):2996-3005
pubmed: 28747370
Euro Surveill. 2020 Mar;25(12):
pubmed: 32234118
J Fungi (Basel). 2019 Oct 03;5(4):
pubmed: 31623348

Auteurs

Ashley Sharp (A)

Field Epidemiology Training Programme, Public Health England, London, United Kingdom.

Berit Muller-Pebody (B)

National Infection Service, Public Health England, London, United Kingdom.

Andre Charlett (A)

National Infection Service, Public Health England, London, United Kingdom.

Bharat Patel (B)

National Infection Service, Public Health England, London, United Kingdom.

Rebecca Gorton (R)

Health Service Laboratories, LLP, London, United Kingdom.

Jonathan Lambourne (J)

Barts Health NHS Trust, London, United Kingdom.

Martina Cummins (M)

Barts Health NHS Trust, London, United Kingdom.

Adela Alcolea-Medina (A)

Barts Health NHS Trust, London, United Kingdom.

Mark Wilks (M)

Barts Health NHS Trust, London, United Kingdom.

Robin Smith (R)

Department of Infection, Royal Free London NHS Foundation Trust, London, United Kingdom.

Damien Mack (D)

Department of Infection, Royal Free London NHS Foundation Trust, London, United Kingdom.

Susan Hopkins (S)

National Infection Service, Public Health England, London, United Kingdom.
Department of Infection, Royal Free London NHS Foundation Trust, London, United Kingdom.

Andrew Dodgson (A)

National Infection Service, Public Health England, London, United Kingdom.
Manchester University NHS Foundation Trust, Manchester, United Kingdom.

Phillipa Burns (P)

Manchester University NHS Foundation Trust, Manchester, United Kingdom.

Nelun Perera (N)

University Hospitals of Leicester NHS Trust, Leicester, United Kingdom.

Felicia Lim (F)

University Hospitals of Leicester NHS Trust, Leicester, United Kingdom.

Gopal Rao (G)

London North West University Healthcare NHS Trust, London, United Kingdom.

Priya Khanna (P)

London North West University Healthcare NHS Trust, London, United Kingdom.

Elizabeth Johnson (E)

National Infection Service, Public Health England, London, United Kingdom.

Andrew Borman (A)

National Infection Service, Public Health England, London, United Kingdom.

Silke Schelenz (S)

Royal Brompton Hospital, London, United Kingdom.

Rebecca Guy (R)

National Infection Service, Public Health England, London, United Kingdom.

Joanna Conneely (J)

National Infection Service, Public Health England, London, United Kingdom.

Rohini J Manuel (RJ)

National Infection Service, Public Health England, London, United Kingdom.

Colin S Brown (CS)

National Infection Service, Public Health England, London, United Kingdom.
Department of Infection, Royal Free London NHS Foundation Trust, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH